Analysts' ratings for AbbVie (NYSE:ABBV) over the last quarter vary from bullish to bearish, as provided by 11 analysts.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 9 | 0 | 0 | 0 |
| Last 30D | 1 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 2 | 0 | 0 | 0 |
| 3M Ago | 1 | 6 | 0 | 0 | 0 |
Analysts have recently evaluated AbbVie and provided 12-month price targets. The average target is $208.09, accompanied by a high estimate of $225.00 and a low estimate of $196.00. This upward trend is evident, with the current average reflecting a 6.22% increase from the previous average price target of $195.91.
Investigating Analyst Ratings: An Elaborate Study
The standing of AbbVie among...
Login or create a forever free account to read this news
Sign up/Log in
